Should clarify, maybe not a "priority" over Cantrixl per say, but a smoother sailing i guess, for Anisina, within it's own.
They're both a go. Drugs are chosen, FDA meetings, manufacturing, clinical protocols, etc..
Still will bet, the non-cancer cell line Cantrixl effected, will be an opportunity to cure an additional issue, like Ninja eluded to. Besides, they're writing the protocol, so they definitely do not sound concerned, like it was vaguely stated. Could be setting up for an additional surprise.
Glta!
Chris
- Forums
- ASX - By Stock
- KZA
- Sellers drying up?
Sellers drying up?, page-29
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online